Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 30, 2021

View Archived Issues

Blueprint Medicines to acquire LNG-451 with Lengo Therapeutics acquisition

Oncostatin M targeting as approach for treating inflammatory pruritus

Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism

IBI-319, a novel CD137/PD-1 bispecific antibody with limited systemic toxicity

Shanghai Longwood Biopharmaceuticals divulges PD-1/PD-L1 interaction inhibitors

Dartmouth College discloses new GR antagonists

Txinno Bioscience presents new ENPP1 inhibitors

Eli Lilly and Company identifies CSF1R inhibitors

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

B-cell targeting controls chronic viral infections in mice

New transgenic hACE2-expressing mouse model shows efficacy of vaccine against brain COVID-19

Discovery of novel antifungal compounds with improved metabolic stability

PNV-2 reduces metastases in animal model of triple-negative breast cancer

Scorpion Therapeutics unveils lead programs in cancer

Polyphenylene carboxymethylene shows anti-SARS-CoV-2 activity in vitro

Janssen publishes PK/PD data for the anticoagulant-reversing agent JNJ-67842125

Indomethacin-based PROTACs show pan-coronavirus activity, including SARS-CoV-2 strains

NHD2 is essential in Leishmania independently of complex I, emerging as a potential drug target

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...